LMR Partners »

Protagonist Therapeutics shares owned by LMR Partners

Quarter-by-quarter ownership of Protagonist Therapeutics (PTGX) shares owned by LMR Partners from 13F filings

Historical chart of LMR Partners investment in Protagonist Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Protagonist Therapeutics held by LMR Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Protagonist Therapeutics by LMR Partners

Quarter filed Position value Share count Share price at filing
2025-12-31 $3.5M 40k 87.34
2018-06-30 $210k 31k 6.72

More positions owned by LMR Partners

Spdr Gold Tr Gold Shs (GLD)
Ishares Tr Msci Emg Mkt Etf Call Option (EEM)
NVIDIA Corporation Put Option (NVDA)
Ishares Tr Core S&p500 Etf (IVV)
Strategy Cl A New (MSTR)
Coinbase Global Com Cl A (COIN)
Echostar Corp Note 3.875%11/3 (Principal)
Gamestop Corp Cl A Call Option (GME)
Tesla Motors Put Option (TSLA)
Ishares Silver Tr Ishares Call Option (SLV)
Pdd Holdings Sponsored Ads Call Option (PDD)
Ishares Bitcoin Trust Etf Shs Ben Int Call Option (IBIT)
Amazon Put Option (AMZN)
Meta Platforms Cl A Put Option (META)
Ishares Tr 20 Yr Tr Bd Etf Call Option (TLT)

View all positions for LMR Partners

Top funds holding Protagonist Therapeutics

BlackRock
Farallon Capital Management
Vanguard Group
Rtw Investments
State Street Corporation
UBS Group
BVF
Johnson & Johnson
Wellington Management Company
Invesco
Geode Capital Management
Woodline Partners
Driehaus Capital Management
Henderson Group
ADAR1 Capital Management

View all funds holding Protagonist Therapeutics